Enovis (ENOV) Financials: Revenue & Earnings
ENOV$22.70+0.79 +3.61%
$1.31B
Market Cap
-1.09
P/E
6.26
Forward P/E
60
Score
Enovis (ENOV) Financials: Revenue & Earnings
ENOV price $22.70 +0.79 +3.61%
- Ticker
- ENOV
- Price
- $22.70
- Change
- +0.79 +3.61%
- Market cap ?
- $1.31B
- P/E ?
- -1.09
- Forward P/E ?
- 6.26
- Dividend yield ?
- 0.00%
- Beta ?
- 1.48
- Sector
- Healthcare
- Industry
- Medical - Devices
- Stocklytics score
- 60
- Value
- 70
- Quality
- 43
- Growth
- 66
Stocklytics score rationale: value 70, quality 43, growth 66.
Financials
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
| 3647047000 | 3300184000 | 3666812000 | 3327458000 | 1120700000 | 1426188000 | 1563101000 | 1707197000 | 2107623000 | 2248049000 |
Enovis Corporation is a global medical technology enterprise specializing in the design, production, and supply of medical devices. These specialized products are instrumental for a diverse range of healthcare professionals—including orthopedic specialists, surgeons, general physicians, pain management experts, physical therapists, podiatrists, chiropractors, and athletic trainers—who treat patients with…
Earnings and financials
Enovis Corporation (ENOV) trades at $22.70, with a market cap of $1.31B and a trailing P/E of -1.09. Revenue below is the annual history on file. It describes what the business has already reported. It is not a forecast and it is not a recommendation.
Financials
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
| 3647047000 | 3300184000 | 3666812000 | 3327458000 | 1120700000 | 1426188000 | 1563101000 | 1707197000 | 2107623000 | 2248049000 |
Insights · Dividends · Forecast · Financials · Learn